Group B streptococcal vaccine (Provalis)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameGroup B streptococcal vaccine (Provalis)
Drug Alias NameGroup B Streptococcus vaccine (Provalis)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsStreptococcus group B infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProvalis
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProvalis
Active IndicationsN/A
Inactive IndicationsStreptococcus group B infection

Other Information

ATC CodeN/A
Related LinksN/A